{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:15:51Z","timestamp":1789917351416,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ejim.2012.03.016","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T17:05:08Z","timestamp":1335027908000},"page":"594-598","source":"Crossref","is-referenced-by-count":11,"title":["The association of Raynaud's syndrome with cisplatin-based chemotherapy \u2014 A meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Melvin","family":"Mohokum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schlattmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2012.03.016_bb0005","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynaud's phenomenon","volume":"357","author":"Block","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.03.016_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1024\/0301-1526\/a000003","article-title":"Functional vascular diseases: Raynaud's syndrome, acrocyanosis and erythromelalgia","volume":"39","author":"Heidrich","year":"2010","journal-title":"Vasa"},{"key":"10.1016\/j.ejim.2012.03.016_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11926-002-0007-z","article-title":"Raynaud's phenomenon: epidemiology and risk factors","volume":"4","author":"Fraenkel","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ejim.2012.03.016_bb0020","first-page":"580","article-title":"Vascular toxicity associated with antineoplastic agents","volume":"19","author":"Doll","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JCO.1989.7.7.940","article-title":"Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold","volume":"7","author":"Hansen","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0030","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/1097-0142(19851215)56:12<2765::AID-CNCR2820561208>3.0.CO;2-2","article-title":"Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin","volume":"56","author":"Vogelzang","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2012.03.016_bb0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.7326\/0003-4819-86-6-803","article-title":"Cis-diamminedichloroplatinum (II). A new anticancer drug","volume":"86","author":"Rozencweig","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2012.03.016_bb0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/bjc.1991.129","article-title":"Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study","volume":"63","author":"Heier","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejim.2012.03.016_bb0045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.1988.6.8.1231","article-title":"A randomized trial of etoposide+cisplatin versus vinblastine+bleomycin+cisplatin+cyclophosphamide+dactinomycin in patients with good-prognosis germ cell tumors","volume":"6","author":"Bosl","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0050","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1200\/JCO.1997.15.5.1837","article-title":"Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group","volume":"15","author":"de Wit","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0055","first-page":"905","article-title":"Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer","volume":"70","author":"Eeles","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ejim.2012.03.016_bb0060","unstructured":"Schwarzer G. meta: Meta-Analysis with R. In. 1.5-0 ed; 2010: Fixed and random effects meta-analysis. Functions for tests of bias, forest and funnel plot."},{"key":"10.1016\/j.ejim.2012.03.016_bb0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ejim.2012.03.016_bb0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2012.03.016_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ejim.2012.03.016_bb0080","series-title":"Medical applications of finite mixture models","author":"Schlattmann","year":"2009"},{"key":"10.1016\/j.ejim.2012.03.016_bb0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/00401706.1988.10488400","article-title":"Graphical display of estimates having differing standard errors","volume":"30","author":"Galbraith","year":"1988","journal-title":"Technometrics"},{"key":"10.1016\/j.ejim.2012.03.016_bb0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2012.03.016_bb0095","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ejim.2012.03.016_bb0100","unstructured":"Lumley T. rmeta: Meta-analysis. In. 2.16 ed; 2009."},{"key":"10.1016\/j.ejim.2012.03.016_bb0105","unstructured":"Schlattmann P. Finite Mixture Models and metaanalysis tools - based on C.A.MAN. In. 0.64 ed; 2008."},{"key":"10.1016\/j.ejim.2012.03.016_bb0110","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2012.03.016_bb0115","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0895-4356(90)90101-T","article-title":"Prevalence of Raynaud phenomenon in the adult population of South Carolina","volume":"43","author":"Weinrich","year":"1990","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0120","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10067-005-0077-1","article-title":"Raynaud's phenomenon: prevalence in an Italian population sample","volume":"25","author":"De Angelis","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/art.20988","article-title":"The incidence and natural history of Raynaud's phenomenon in the community","volume":"52","author":"Suter","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2012.03.016_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/oxfordjournals.annonc.a057750","article-title":"Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin","volume":"1","author":"Hansen","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-95-3-288","article-title":"Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer","volume":"95","author":"Vogelzang","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2012.03.016_bb0140","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/oxfordjournals.eurheartj.a062542","article-title":"Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer","volume":"9","author":"Stefenelli","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2012.03.016_bb0145","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ctrv.2009.12.011","article-title":"Late complications of chemotherapy in testicular cancer","volume":"36","author":"Pliarchopoulou","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejim.2012.03.016_bb0150","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1302\/0301-620X.81B6.9765","article-title":"Prevalence of Raynaud's phenomenon in patients with idiopathic carpal tunnel syndrome","volume":"81","author":"Chung","year":"1999","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.ejim.2012.03.016_bb0155","first-page":"879","article-title":"Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison","volume":"24","author":"Maricq","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2012.03.016_bb0160","first-page":"70","article-title":"Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France","volume":"20","author":"Maricq","year":"1993","journal-title":"J Rheumatol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T18:50:52Z","timestamp":1542999052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620512000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0953620512000854"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2012.03.016","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}